UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) ~~March~~ June 118, ~~2022~~2023

Sunwin Stevia International, Inc.

(Exact name of registrant as specified in its charter)

Nevada	000-53595	56-2416925
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

6 Shengwang Avenue, Qufu, Shandong China	273100
(Address of principal executive offices)	(Zip Code)

Registrant's telephone number, including area code

(86) 537- 4424999

not applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered under Section 12(b) of the Act:

Title of each class	Trading Symbol (s)	Name of each exchange on which registered
None	SUWN	Not applicable

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company [ ]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 54.0201 ~~Departure~~Changes ofin ~~Directors~~Registrant’s orCertifying ~~Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.~~Accountant

~~Effective~~On ~~March~~June 118, ~~2022~~2023, ~~Mr. Yuqiang Lai resigned his position as Director of~~ Sunwin Stevia International, Inc.’s (the “Company”), ~~due~~determined tothat ~~personal~~it ~~reasons.~~would Asbe in the best interests of the ~~same~~Company ~~date,~~to ~~Mr.~~terminate ~~Jianjun~~the ~~Yan~~audit ~~resigned~~engagement ~~their~~with ~~positions~~RBSM asLLP ~~Director~~(“RBSM”), ~~and~~in ~~CEO~~consideration of ~~Sunwin~~the ~~Stevia~~cash ~~International,~~flow ~~Inc~~situation.’s (In the ~~“Company”)~~recent years, due to ~~personal~~effects ~~reasons. Mr.~~from ~~Lai’s~~the global pandemic and ~~Mr.~~various ~~Yan’s~~market ~~resignation~~factors, the company has experience increasing difficulties to maintain a positive cash flow and unfortunately is ~~not~~having ~~due~~to make difficult decisions to ~~any~~significantly ~~disagreement~~decrease ~~with~~certain ~~the~~operating ~~Company~~costs onto ~~any~~stay ~~matter~~in ~~related~~business. We plan to ~~operations,~~temporarily ~~policies,~~terminate orour ~~practices~~audit services and will reengage an independent auditor in the near future when our cash flow improves.

OnThe ~~March~~principal ~~11,~~accountant's ~~2022,~~reports ~~the~~of ~~Company~~RBSM ~~appointed~~on ~~Mr.~~the ~~Chunchun~~financial ~~Wang~~statements ~~as a Director and CEO~~ of the Company. ~~Mr.~~as ~~Wang~~of ~~has~~its ~~been~~engagement ~~working in the pharmaceutical industry~~ since ~~his~~2013 ~~graduation~~did ~~from~~not ~~Qufu~~contain ~~Yuandong~~any ~~Professional~~adverse ~~Technical~~opinion ~~College~~or indisclaimer ~~2005 and has been working with the Company since March 2006 in various positions in our technology and web-based sales departments and is currently serving as the General Manager~~ of ~~web-based~~opinion ~~operations. We believe Mr. Wang’s expertise~~ and ~~experience~~were innot ~~the~~qualified ~~industry~~or asmodified ~~well~~ as ~~his experience with us will be greatly beneficial~~ to ~~the~~audit ~~future~~scope ~~growth~~or ofaccounting ~~the Company~~principles. ~~Mr. Wang is not a party of any related party transactions with the Company.~~

OnSince ~~March 11, 2022,~~ the ~~Company~~engagement ~~appointed~~of ~~Ms.~~RBSM ~~Fanjun~~in Wu2013 asand aduring ~~Director of~~ the ~~Company.~~two ~~Ms.~~years Wuended ~~has been our Chief Financial Officer since~~ April 30, ~~2004.~~2022 ~~Since~~and ~~1997,~~2021 ~~she~~and ~~has~~through ~~been~~the ~~employed~~date byof ~~Qufu~~this ~~Natural Green~~8-K, ~~serving~~there aswere ~~Director~~no ofdisagreements ~~Finance~~with ~~from~~RBSM ~~1997~~on toany ~~1998~~matter ~~and~~of ~~thereafter~~accounting asprinciples ~~Chief~~or ~~Financial~~practices, ~~Officer.~~financial ~~From~~statement ~~1992 to 1996~~disclosure, ~~Ms.~~or Wuauditing ~~was~~scope aor ~~Director of Finance for our subsidiary Shengya Veterinary Medicine~~procedure, which ~~was~~if ~~owned~~not byresolved ~~Shandong Group prior~~ to ~~our~~RBSM’s ~~acquisition~~satisfaction inwould ~~2004.~~have ~~Ms.~~caused Wuit ~~graduated~~to ~~from~~make ~~Qufu~~reference ~~Industrial~~thereto ~~College~~ in ~~1995~~connection with aits ~~Bachelor's~~reports ~~Degree~~on inthe ~~Accounting.~~financial Westatements ~~believe~~for Mssuch years. ~~Wu’s~~During ~~expertise~~the ~~and~~two ~~experience~~years inended ~~the~~April ~~industry~~30, as2022 ~~well~~and asthrough ~~her~~the ~~experience~~date ~~with~~of usthis ~~will~~8-K, bethere ~~greatly~~were ~~beneficial~~no toreportable ~~the~~events ~~future growth~~ of the ~~Company.~~type ~~Ms.~~described Wuin isItem ~~not~~ 304(a)(1)(v) ~~party~~ of ~~any~~Regulation ~~related party transactions with the Company~~S-K.

~~SIGNATURES~~During the two years ended April 30, 2022 and through the date of this 8-K, the Company did not consult with RBSM with respect to any of (i) the application of accounting principles to a specified transaction, either completed or proposed; (ii) the type of audit opinion that might be rendered on the Company's financial statements; or (iii) any matter that was either the subject of a disagreement (as defined in Item 304(a)(1)(iv) of Regulation S-K) or an event of the type described in Item 304(a)(1)(v) of Regulation S-K.

~~Pursuant~~The Company provided RBSM with a copy of the foregoing disclosure and requested RBSM to furnish the ~~requirements~~Company ofwith a letter addressed to the Securities and Exchange ~~Act~~Commission ofstating ~~1934,~~whether it agrees with the ~~registrant~~statements ~~has~~made ~~duly~~therein. ~~caused~~A ~~this~~copy ~~report~~of tosuch beletter, ~~signed~~dated onJune ~~its~~8, ~~behalf~~2023, furnished by ~~the~~RBSM, ~~undersigned~~is ~~hereunto~~filed ~~duly~~as ~~authorized~~Exhibit 16.1 to this Current Report on Form 8-K.

	SUNWIN STEVIA INTERNATIONAL, INC.
Date: March 14, 2022	By: /s/ Chunchun Wang
	Chunchun Wang, Chief Executive Officer

Item 9.01

Financial Statements and Exhibits

(d)

Exhibits

16.1

Letter dated June 8, 2023 from RBSM LLP to the Securities and Exchange Commission.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: June 9, 2023		Sunwin Stevia International Inc.


		By: /s/ Chunchun Wang
		Chunchun Wang
		Chief Executive Officer

Filing Compare · SUNWIN STEVIA INTERNATIONAL, INC.